1. Home
  2. Live Updates
  3. Immpact bio

Live Breaking News & Updates on Immpact bio

Stay informed with the latest breaking news from Immpact bio on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Immpact bio and stay connected to the pulse of your community

ViroCell Biologics: ViroCell to present at 2024 Cell & Gene Meeting on the Med

ViroCell Biologics: ViroCell to present at 2024 Cell & Gene Meeting on the Med
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Italy , Roma , Lazio , Rome , Farzin-farzaneh , Laura-stringham , Sumant-ramachandra , Virocell-biologics , Foster-mitchell-tim-stamper , Alberto-cadlolo , Benjamin-dewees , Immpact-bio

ImmPACT Bio to Present at the BIO Investor Forum

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

San-francisco , California , United-states , Sumant-ramachandra , Investor-forum , Prnewswire-immpact-bio-united-states-inc , Opportunities-in-bispecific-therapy-development , Bio-united-states , Bispecific-therapy-development , Immpact-bio ,

ImmPACT Bio to Present at Cell & Gene Meeting on the Mesa

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

Sumant-ramachandra , Prnewswire-immpact-bio-united-states-inc , Bio-united-states , Gene-meeting , Immpact-bio ,

ImmPACT Bio Doses First Patient in Phase 1/2 Trial Evaluating IMPT-314, a Bispecific CD19/CD20 CAR T-cell Therapy for the Treatment of Aggressive B-cell Lymphoma

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

California , United-states , Los-angeles , Sarah-larson , Yvonne-chen , Jonathan-benjamin , University-of-california , Prnewswire-immpact-bio-united-states-inc , Drug-administration , Fast-track-designation , Bio-united-states , David-geffen-school

ImmPACT Bio to Present at Jefferies Cell & Genetic Medicine Summit

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

New-york , United-states , Sumant-ramachandra , Prnewswire-immpact-bio-united-states-inc , Bio-united-states , Jefferies-cell , Genetic-medicine-summit , Immpact-bio ,

ImmPACT Bio Announces FDA Clearance of IND Application for Bispecific CD19/CD20 CAR T Therapy IMPT-514 for the Treatment of Refractory Systemic Lupus Erythematosus

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

California , United-states , Los-angeles , Sumant-ramachandra , Sarah-larson , Yvonne-chen , Drug-administration , Prnewswire-immpact-bio-united-states-inc , University-of-california , Bio-united-states , Activity-index , Immpact-bio

ImmPACT Bio to Present at the 2023 Jefferies Healthcare Conference

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

New-york , United-states , Sumant-ramachandra , Prnewswire-immpact-bio-united-states-inc , Bio-united-states , Healthcare-conference , Immpact-bio ,

ImmPACT Bio Granted FDA Fast Track Designation for IMPT-314 in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

California , United-states , Los-angeles , Sumant-ramachandra , Sarah-larson , Yvonne-chen , University-of-california , Drug-administration , Prnewswire-immpact-bio-united-states-inc , Bio-united-states , Fast-track-designation , Immpact-bio

ImmPACT Bio Announces Opening of California-Based GMP Facility for Clinical Production of IMPT-314, a CD19/CD20 CAR T Therapy for B-Cell Malignancies and Autoimmune Diseases

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

California , United-states , Los-angeles , Sarah-larson , Sumant-ramachandra , Sylvain-roy , Yvonne-chen , Technology-development-group , Prnewswire-immpact-bio-united-states-inc , University-of-california , Bio-united-states , Good-manufacturing-practices

ImmPACT Bio Appoints Biren Amin, M.B.A. to its Board of Directors

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...

Philadelphia , Pennsylvania , United-states , Sumant-ramachandra , Biren-amin , Sheila-gujrathi , Prnewswire-immpact-bio-united-states-inc , Jefferies-financial-group , Long-island-university , Pyramid-biosciences-inc , University-of-sciences , Aventis-pharmaceuticals